ES2063912T3 - Composiciones inmunogenicas frente a peptidos de gastrina. - Google Patents
Composiciones inmunogenicas frente a peptidos de gastrina.Info
- Publication number
- ES2063912T3 ES2063912T3 ES90300456T ES90300456T ES2063912T3 ES 2063912 T3 ES2063912 T3 ES 2063912T3 ES 90300456 T ES90300456 T ES 90300456T ES 90300456 T ES90300456 T ES 90300456T ES 2063912 T3 ES2063912 T3 ES 2063912T3
- Authority
- ES
- Spain
- Prior art keywords
- immunogenic compositions
- disclosed
- gastrine
- peptides
- compositions against
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/595—Gastrins; Cholecystokinins [CCK]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
COMPOSICIONES INMUNOGENICAS UTILES EN EL TRATAMIENTO DE ULCERAS O TUMORES CUYO CRECIMIENTO DEPENDA DE HORMONAS DE GASTRINA O SE ESTIMULE CON ELLAS. LAS COMPOSICIONES INMUNOGENICAS INDUCEN A LOS ANTICUERPOS DE UN SUJETO QUE NEUTRALICEN SELECTIVAMENTE LAS HORMONAS ESPECIFICAS. TAMBIEN SE REVELAN COMPOSICIONES FARMACEUTICAS QUE CONSTEN DE CANTIDADES EFECTIVAS DE LAS COMPOSICIONES INMUNOGENICAS Y METODOS DE TRATAMIENTO CON LAS MISMAS, ASI COMO UN METODO PARA INVERTIR LOS TRATAMIENTOS INVENTIVOS MEDIANTE LA NEUTRALIZACION DE LOS ANTICUERPOS INDUCIDOS "IN VIVO".
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/301,353 US5023077A (en) | 1989-01-24 | 1989-01-24 | Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease |
US35119389A | 1989-05-12 | 1989-05-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2063912T3 true ES2063912T3 (es) | 1995-01-16 |
Family
ID=26972322
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90300456T Expired - Lifetime ES2063912T3 (es) | 1989-01-24 | 1990-01-17 | Composiciones inmunogenicas frente a peptidos de gastrina. |
Country Status (12)
Country | Link |
---|---|
US (3) | US5607676A (es) |
EP (1) | EP0380230B1 (es) |
JP (1) | JP2526418B2 (es) |
AT (1) | ATE114160T1 (es) |
AU (1) | AU645967B2 (es) |
CA (1) | CA2045594C (es) |
DE (1) | DE69014137T2 (es) |
DK (1) | DK0380230T3 (es) |
ES (1) | ES2063912T3 (es) |
IE (1) | IE66267B1 (es) |
PT (1) | PT92938B (es) |
WO (1) | WO1990008774A1 (es) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5023077A (en) * | 1989-01-24 | 1991-06-11 | Aphton Corporation | Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease |
US6861510B1 (en) * | 1989-01-24 | 2005-03-01 | Aphton Corporation | Immunogenic compositions against gastrin peptides |
ATE114160T1 (de) * | 1989-01-24 | 1994-12-15 | Aphton Corp | Immunogenische zusammensetzungen gegen gastrin- peptide. |
US5468494A (en) * | 1993-11-12 | 1995-11-21 | Aphton Corp. | Immunogenic compositions against human gastrin 17 |
US5688506A (en) * | 1994-01-27 | 1997-11-18 | Aphton Corp. | Immunogens against gonadotropin releasing hormone |
GB9406974D0 (en) * | 1994-04-08 | 1994-06-01 | Pharmaceutical Proteins Ltd | Transgenic production |
PT889735E (pt) * | 1996-02-08 | 2011-07-19 | Cancer Advances Inc | Métodos imunológicos para o tratamento do cancro gastrointestinal |
US6072086A (en) * | 1996-04-12 | 2000-06-06 | Intergen Company | Method and composition for controlling formaldehyde fixation by delayed quenching |
CA2288027A1 (en) * | 1997-04-23 | 1998-10-29 | The Regents Of The University Of Michigan | Bradykinin analogs as selective inhibitors of cell activation |
US6982249B1 (en) | 1997-04-23 | 2006-01-03 | The Regents Of The University Of Michigan | Bradykinin analogs as selective inhibitors of cell activation |
NZ500748A (en) * | 1997-05-12 | 2001-06-29 | Aphton Corp | Methods for the treatment of gastrin-dependent tumours comprising active or passive immunisation with an anti-CCK-B/gastrin receptor immunogen or anti-CCK-B/gastrin receptor antibodies |
US20040001842A1 (en) * | 1997-05-12 | 2004-01-01 | Dov Michaeli | Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors |
WO1999059612A1 (en) * | 1998-05-15 | 1999-11-25 | Aphton Corporation | Method for the treatment of gastroesophageal reflux disease |
US20030068326A1 (en) * | 1998-05-15 | 2003-04-10 | Aphton Corporation | Method for the treatment of gastroesophageal reflux disease |
DE69935977T2 (de) * | 1998-05-15 | 2008-01-10 | Receptor Biologix, Inc., Palo Alto | Vorbeugung und Behandlung von Hypergastrinämie |
EP1897556A1 (en) * | 1998-05-15 | 2008-03-12 | Receptor Biologix, Inc. | Prevention and treatment of hypergastrinemia |
ES2237103T3 (es) * | 1998-05-15 | 2005-07-16 | Aphton Corporation | Terapia de combinacion para el tratamiento de tumores. |
EP1579863A3 (en) * | 1998-05-15 | 2008-03-19 | Receptor Biologix, Inc. | Combination therapy with anti-gastrin G17 antibodies for the treatment of tumors |
AU768612B2 (en) * | 1998-06-18 | 2003-12-18 | Vecta Ltd | Pharmaceutical compositions for the treatment of (helicobacter pylori)-associated disorders |
JP2005508838A (ja) * | 2001-03-23 | 2005-04-07 | アフトン コーポレーション | 膵癌の組合せ治療 |
US20090191232A1 (en) | 2001-05-04 | 2009-07-30 | Gevas Philip C | Combination therapy for the treatment of tumors |
AU2002326356A1 (en) * | 2001-07-09 | 2003-01-29 | Aphton Corporation | Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus |
EP1837031B1 (en) * | 2002-06-07 | 2009-10-14 | Waratah Pharmaceuticals, Inc. | Compositions and methods for treating diabetes |
US20050169979A1 (en) * | 2002-07-03 | 2005-08-04 | Dov Michaeli | Liposomal vaccine |
CA2501677A1 (en) * | 2002-10-22 | 2004-05-06 | Waratah Pharmaceuticals, Inc. | Treatment of diabetes |
US20080096824A1 (en) * | 2003-02-28 | 2008-04-24 | Shigemi Matsuyama | Ku-70-derived bax-suppressing peptides and use thereof for the protection of damaged cells |
US7235376B2 (en) | 2003-03-28 | 2007-06-26 | Receptor Biologix, Inc. | Gastrin hormone immunoassays |
CN1997669A (zh) * | 2004-03-29 | 2007-07-11 | 受体生物技术公司 | 抗胃泌素激素单克隆抗体 |
WO2005095459A2 (en) * | 2004-03-29 | 2005-10-13 | Receptor Biologix, Inc. | Monoclonal antibodies to gastrin hormone |
EP2567974A3 (en) * | 2004-09-22 | 2013-05-22 | Cancer Advances, Inc., | Monoclonal antibodies to progastrin |
GB201121571D0 (en) * | 2011-12-15 | 2012-01-25 | Astrimmune Ltd | Compounds and uses thereof |
CN109806387B (zh) | 2012-07-13 | 2022-03-04 | S-目标疗法有限公司 | 免疫调节疫苗 |
JP6395816B2 (ja) * | 2013-05-21 | 2018-09-26 | ティーワイジー・オンコロジー・リミテッド | ガストリンペプチド免疫原組成物 |
CA3066756A1 (en) | 2017-06-15 | 2018-12-20 | Cancer Advances Inc. | Compositions and methods for inducing humoral and cellular immunities against tumors and cancer |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3932242A (en) * | 1957-11-21 | 1976-01-13 | Bartley Charles E | Solid propellant with butyl rubber binder |
DE2256445C3 (de) * | 1972-11-17 | 1981-11-05 | Hoechst Ag, 6000 Frankfurt | Heptapeptide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate |
US4384995A (en) * | 1980-01-16 | 1983-05-24 | The Ohio State University | Antigenic modification of polypeptides |
US4526716A (en) * | 1981-11-20 | 1985-07-02 | The Ohio State University | Antigenic modification of polypeptides |
US4691006A (en) * | 1983-03-04 | 1987-09-01 | Ohio State University | Antigenic modification of polypeptides |
SU1414392A1 (ru) * | 1982-12-29 | 1988-08-07 | Всесоюзный кардиологический научный центр АМН СССР | Противо звенное средство |
FR2575164B1 (fr) * | 1984-12-20 | 1987-03-20 | Sanofi Sa | Esters de tri- et tetrapeptides inhibiteurs de la secretion gastrique, procede d'obtention et compositions pharmaceutiques les contenant |
US5023077A (en) * | 1989-01-24 | 1991-06-11 | Aphton Corporation | Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease |
ATE114160T1 (de) * | 1989-01-24 | 1994-12-15 | Aphton Corp | Immunogenische zusammensetzungen gegen gastrin- peptide. |
US5468494A (en) * | 1993-11-12 | 1995-11-21 | Aphton Corp. | Immunogenic compositions against human gastrin 17 |
-
1990
- 1990-01-17 AT AT90300456T patent/ATE114160T1/de not_active IP Right Cessation
- 1990-01-17 ES ES90300456T patent/ES2063912T3/es not_active Expired - Lifetime
- 1990-01-17 EP EP90300456A patent/EP0380230B1/en not_active Expired - Lifetime
- 1990-01-17 DK DK90300456.2T patent/DK0380230T3/da active
- 1990-01-17 DE DE69014137T patent/DE69014137T2/de not_active Expired - Fee Related
- 1990-01-23 CA CA002045594A patent/CA2045594C/en not_active Expired - Fee Related
- 1990-01-23 US US07/721,638 patent/US5607676A/en not_active Expired - Fee Related
- 1990-01-23 PT PT92938A patent/PT92938B/pt not_active IP Right Cessation
- 1990-01-23 AU AU50820/90A patent/AU645967B2/en not_active Ceased
- 1990-01-23 WO PCT/US1990/000520 patent/WO1990008774A1/en active Application Filing
- 1990-01-23 IE IE25090A patent/IE66267B1/en not_active IP Right Cessation
- 1990-01-23 JP JP2503438A patent/JP2526418B2/ja not_active Expired - Lifetime
-
1994
- 1994-08-04 US US08/285,984 patent/US5609870A/en not_active Expired - Lifetime
-
1995
- 1995-06-05 US US08/462,158 patent/US5785970A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU5082090A (en) | 1990-08-24 |
EP0380230A3 (en) | 1991-06-26 |
IE66267B1 (en) | 1995-12-27 |
JP2526418B2 (ja) | 1996-08-21 |
IE900250L (en) | 1990-07-24 |
US5607676A (en) | 1997-03-04 |
WO1990008774A1 (en) | 1990-08-09 |
US5609870A (en) | 1997-03-11 |
PT92938B (pt) | 1996-09-30 |
JPH04503072A (ja) | 1992-06-04 |
DK0380230T3 (da) | 1995-01-16 |
US5785970A (en) | 1998-07-28 |
CA2045594C (en) | 2002-08-13 |
DE69014137T2 (de) | 1995-06-08 |
ATE114160T1 (de) | 1994-12-15 |
PT92938A (pt) | 1990-07-31 |
EP0380230A2 (en) | 1990-08-01 |
AU645967B2 (en) | 1994-02-03 |
CA2045594A1 (en) | 1990-07-25 |
DE69014137D1 (de) | 1994-12-22 |
EP0380230B1 (en) | 1994-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2063912T3 (es) | Composiciones inmunogenicas frente a peptidos de gastrina. | |
ATE60697T1 (de) | Verfahren zur bekaempfung von pilzen. | |
DE69010893D1 (de) | Verfahren zur behandlung von koks sowie löschen desselben. | |
DE69231294D1 (de) | Vorrichtung zur behandlung von tumoren | |
NO933126D0 (no) | Loeselige ligander for cd40 | |
DE69303803D1 (de) | Behandlungsmethode zur Bodenverfestigung | |
DE3856594D1 (de) | Mittel zur behandlung der alzheimer-krankheit | |
DK90888A (da) | Maaleapparat til vaevsmetabolisme | |
ES2013631B3 (es) | Metodo para el tratamiento de tejidos. | |
DE68917433D1 (de) | Verfahren zur behandlung von asbest sowie asbestbehandlungsmittel. | |
DE3854121D1 (de) | Arzneimittelzusammensetzungen zur behandlung von psoriasis. | |
DE3856329D1 (de) | Verwendung von Ethisterone zur topischen Behandlung von Akne oder androgenetischer Alopezie | |
DE69818809D1 (de) | Verfahren zur behandlung von narbengewebe | |
ATE181240T1 (de) | Verwendung von somatostatinanalogen zur behandlung von melanomen | |
NO880292D0 (no) | Fremgangsmaate for behandling av humle. | |
DE3873846D1 (de) | Behandlungsapparat und verfahren. | |
BR9007738A (pt) | Metodo de tratamento de couros | |
ATE306278T1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
MX9200755A (es) | Tratamiento de carcinoma pulmonar de celulas no pequeñas. | |
DE68909750D1 (de) | Vorrichtung zur therapeutischen behandlung von lumbago sowie lumbago/ischias. | |
DE3878137D1 (de) | Behandlungsmethode zur bodenstabilisierung. | |
SU619185A1 (ru) | Способ лечени злокачественных опухолей органов малого таза | |
NO905345D0 (no) | Fremgangsmaate og innretning for behandling av elektroforesebaerere. | |
ATA176389A (de) | Verfahren und einrichtung zur stoffbehandlung bzw. -reaktion | |
EP0321094A3 (en) | Treatment of factor viii inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 380230 Country of ref document: ES |